Skip to main content

Basel Medical Group Ltd

corporate_fare Company Profile

Basel Medical Group Ltd

BMGL·NASDAQ·Industrial Applications And Services·CIK 0002004489

Basel Medical Group Ltd is a business company incorporated in the BVI on August 10, 2023, with operations conducted by its subsidiaries based in Singapore. The company's first orthopedic-focused clinic was established in Singapore in 2001, and its first subsidiary, SSO Clinic, was incorporated in 2004. From 2004 to the 2020s, the group, Singmed Specialists, expanded its orthopedic specialty operations, operating two clinics in Singapore: Spine & Orthopaedics Centre (Singapore) and Singapore Sports & Orthopaedics Clinic. In June 2023, AIP Investment Partners Pte. Ltd., through its sub-fund Basel Medical Fund, acquired Singmed Specialists, which was then renamed Basel Medical Group. In February 2025, Basel Medical Group Ltd listed on NASDAQ. On April 11, 2025, Basel Medical Group Pte. Ltd., a subsidiary, entered into an agreement to acquire all ordinary shares of Bethesda Medical Pte. Ltd. for a total consideration of US$6.5 million. This acquisition was completed on April 30, 2025, making Bethesda Medical a wholly owned indirect subsidiary. Through Bethesda Medical, the Group operates six general practice clinics in Singapore. The company's principal executive office is located at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore 258499.

Basel Medical Group Ltd (NASDAQ:BMGL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BMGL SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Basel Medical Group Announces 1-for-12 Reverse Stock Split to Maintain Nasdaq Listing
  • Basel Medical Group Appoints Alton Neo as Interim CFO Following Jianing Lu's Resignation
  • Basel Medical Group Resolves Nasdaq Periodic Filing Deficiency
  • Basel Medical Group Faces Nasdaq Delisting, Reports $8.1M Goodwill Impairment & FY25 Net Loss
  • Basel Medical Group Receives Nasdaq Delinquency Notice for Sub-$1 Bid Price

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$8.9M
Net Income
-$8.36M
Diluted EPS
-$0.45
Op. Cash Flow
-$3.18M
Free Cash Flow
-$3.62M
Cash & Equivalents
$2.39M
Total Debt
$2.32M
Debt / Equity
0.54×
Net Margin
-94.0%
Shares Outstanding
18.79M sh
Source: 20-F · filed 2026-03-13 · accession 0001493152-26-009978

Insider Transactions

BMGL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →
$0.5601 -0.03% today
52-week range · as of 2026-06-10 $0.383 – $5.07
Market cap
$11.08M
Volume
80.9K (0.1× avg)
3-mo avg 1.2M
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BMGL - Latest Insights

BMGL
Jun 10, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.621
Real-time Price: $0.5601 info
Change: -$0.0609 (-10%) info
Market Cap: $11.082M info
BMGL
Jun 05, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3748
Real-time Price: $0.5601 info
Change: +$0.1853 (+49%) info
Market Cap: $11.082M info
BMGL
Mar 24, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7122
Real-time Price: $0.5601 info
Change: -$0.1521 (-21%) info
Market Cap: $11.082M info
BMGL
Mar 13, 2026, 7:30 AM EDT
Filing Type: 20-F/A
Importance Score:
9
Price at Filing: $0.5827
Real-time Price: $0.5601 info
Change: -$0.0226 (-4%) info
Market Cap: $11.082M info
BMGL
Jan 23, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7999
Real-time Price: $0.5601 info
Change: -$0.2398 (-30%) info
Market Cap: $11.082M info
BMGL
Jan 21, 2026, 8:20 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8123
Real-time Price: $0.5601 info
Change: -$0.2522 (-31%) info
Market Cap: $11.082M info